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The role of exercise in Amyotrophic lateral sclerosis (ALS) pathogenesis is controversial
and unclear. Exercise induces a pleiotropic adaptive response in skeletal muscle, largely
through the peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α),
a transcriptional coactivator that regulates mitochondrial biogenesis and antioxidant
defense mechanisms. It has been suggested that a Gly482Ser substitution in PGC-1α
has functional relevance in human disorders and in athletic performance. To test this
hypothesis, we examined the genotype distribution of PGC-1α Gly482Ser (1444 G > A)
in ALS patients to evaluate whether or not the minor serine-encoding allele 482Ser
is involved in oxidative stress responses during physical exercise. We genotyped
197 sporadic ALS patients and 197 healthy controls in order to detect differences
in allelic frequencies and genotype distribution between the two groups. A total of
74 ALS patients and 65 controls were then comparatively assessed for plasmatic
levels of the oxidative stress biomarkers, advanced oxidation protein products,
ferric reducing ability and thiol groups. In addition a subgroup of 35 ALS patients
were also assessed for total SOD and catalase plasmatic activity. Finally in 28 ALS
patients we evaluated the plasmatic curve of the oxidative stress biomarkers and
lactate during an incremental exercise test. No significant differences were observed
in the genotype distribution and allelic frequency in ALS patients compared to
the controls. We found significant increased advanced oxidation protein products
(p < 0.001) and significant decreased ferric reducing ability (p < 0.001) and
thiol groups (p < 0.001) in ALS patients compared to controls. When comparing
different genotypes of PGC-1α, no relation between Gly482Ser polymorphism and
oxidative stress biomarker levels was detected in resting conditions. On the other
hand, when considering exercise performance, lactate levels were significantly higher
Abbreviations: ALS-FRS-R, Amyotrophic lateral sclerosis functional rating scale; AOPP, advanced oxidation protein
products; ALS, amyotrophic lateral sclerosis; DTNB, dithiobis nitrobenzoic acid; fALS, fALS amyotrophic lateral sclerosis;
FRAP, ferric reducing antioxidant power; MVC, maximum voluntary contraction; MEF2, myocyte enhancer factor 2;
PGC-1α, peroxisome proliferator activated receptor gamma coactivator 1 alpha; PBS, phosphate buffered saline; ROS,
reactive oxygen species; RFLP, restriction fragment length polymorphism; SNPs, single nucleotide polymorphisms; SOD,
superoxide dismutase; SOD1, superoxide dismutase-1.
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(between p < 0.01 and p < 0.001) and greater protein oxidative products were found in
AA (Ser482Ser) compared to GG (Gly482Gly) and GA (Gly482Ser) ALS patients. Our
findings highlight the importance and confirm the involvement of oxidative stress in
ALS pathogenesis. Although not associated with 1444 G > A SNP, ALS patients with
Gly482Ser allelic variant show increased exercise-related oxidative stress. This thus
highlights the possible role of this antioxidant defense transcriptional coactivator
in ALS.
Keywords: amyotrophic lateral sclerosis, exercise, oxidative stress, PGC-1α, polymorphisms
INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is the most common
neurodegenerative disorder of motor neurons. Loss of pyramidal,
spinal, and bulbar motor neurons affecting multiple regions
of the body leads to progressive motor dysfunction, disability
and death. It is clinically characterized by progressive paralysis
and eventual death from respiratory failure within 2–5 years
(Wijesekera and Leigh, 2009; D’Amico et al., 2013).
ALS is mainly a sporadic disease (sALS) however
approximately 10% of ALS cases are familial (fALS; Ticozzi
et al., 2011), due to mutations in several genes, which can play
an important role in understanding the pathogenesis of fALS
and sporadic ALS (Ingre et al., 2015). The distribution of fALS
and sporadic cases also depends on the ancestral origin of the
population, since the frequency of ALS-associated genes, as
well as environmental factors vary significantly across different
populations (Marin et al., 2015).
ALS is a complex and multifactorial disease characterized by
the involvement of several pathogenic conditions, including
glutamatergic excitotoxicity (Matsumoto et al., 2007),
mitochondrial dysfunction (Shi et al., 2010), defects in RNA
maturation (Matsumoto et al., 2007) and oxidative stress
(Robberecht, 2000). Oxidative stress biomarkers have been
investigated in several studies and show high protein carbonyl
levels, increased lipid peroxidation and DNA/RNA oxidative
modifications, in the nervous and peripheral tissues in both
sporadic and fALS ALS patients (Chang et al., 2008; Barber and
Shaw, 2009; Kabuta et al., 2015).
ALS occurs in all socio-professional categories with a higher
prevalence in athletes and in individuals who practice intense
and competitive activities. In fact the association of strenuous
physical activity with genetic predisposition and external factors,
such as chemicals used in the sanitizing sports grounds, or
head injuries suffered by players during games, can increase
the risk of developing ALS in some individuals (Scarmeas
et al., 2002; Chiò et al., 2005). Conversely moderate activity has
been shown to be protective for ALS in mice (Carreras et al.,
2010).
Acute exercise is known to induce a transient increase in
reactive oxygen species (ROS), as shown by several reports
of increased oxidative damage following acute bouts of
erobic and anerobic exercise (Fisher-Wellman and Bloomer,
2009). Although the results are somewhat mixed and appear
disease dependent, individuals with chronic disease experience
an exacerbation in oxidative stress following acute exercise
compared to healthy individuals (Fisher-Wellman and Bloomer,
2009). However the relationship between physical activity and
oxidative stress is far from linear (Pittaluga et al., 2006),
since physical activity is associated with favorable changes
in blood pressure, and lipid and lipoprotein profiles, which
reduce the risks of several oxidative stress associated diseases. In
addition, recent research shows that physical activity contributes
significantly to a longer life in good health (Fraile-Bermúdez
et al., 2015).
It is still unclear which of these mechanisms are the primary
causes or consequences of ALS pathogenesis. Several proteins
have been identified that may be involved in the mechanisms
of ALS pathogenesis, including the Peroxisome proliferator
activated receptor gamma coactivator 1 Alpha (PGC-1α;
Qi et al., 2015). PGC-1α is a tissue-specific transcriptional
coactivator, encoded by the gene PPARGC1A/PGC-1α, located
on chromosome 4 (4p15.1), consisting of 13 exons (Arany,
2008).
PGC-1α has an N-terminal domain, containing the sites
for the activator proteins, a central region containing the
sites for the transcription factors which interact with PGC-1α,
and a C-terminal domain containing a binding site for RNA
(Monsalve et al., 2000). PGC-1α activates different metabolic
pathways in response to nutritional and environmental stimuli
such as fasting, cold and physical activity (Handschin et al.,
2007a). In physiological conditions, PGC-1α is located in the
cytoplasm in an inactive state. During muscle contraction or
exercise, it is activated and moves into the nucleus where it
promotes the transcription of genes involved in mitochondrial
biogenesis, oxidative phosphorylation, skeletal muscle fiber
composition remodeling and antioxidant defense (Puigserver
and Spiegelman, 2003; Valle et al., 2005; Liang and Ward,
2006).
Studies in mice models of ALS (SOD1 G93A and SOD1
G37R mouse) and Duchenne muscular dystrophy (mdx mouse;
Sheng et al., 2012) have shown that increased expression and
activity of PGC-1α can improve the clinical manifestations
(Handschin et al., 2007b; Liang et al., 2011) by increasing
mitochondrial biogenesis and ROS detoxification (Austin and
St-Pierre, 2012). Da Cruz et al. (2012) have shown that increased
PGC-1α activity in G37R improves muscular endurance,
reduces atrophy and improves locomotor activity also in
the advanced stages of disease. Liang et al. (2011) showed
that PGC-1α expression declines with ALS development in
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SOD1 G93A mice and that PGC-1α overexpression slows the
disease progression also moderately extending the lifespan,
without any effect on disease onset. The motor activity
was also improved, with a significant decrease in motor
neuron cell death and neuromuscular junction damage,
thus suggesting that increased PGC-1α expression may be
important for ameliorating ALS progression (Liang et al.,
2011).
The gene PGC-1α exists in several allelic variants
that differ from the common allele in terms of a single
nucleotide (Steinbacher et al., 2015). Among single nucleotide
polymorphisms (SNPs), the G to A substitution at position 1444
in exon 8 of the PCG-1α gene, results in the substitution of
glycine with serine in codon 482 and has been associated with
a lower gene expression and reduced PCG-1α protein activity
(Prior et al., 2012).
Several studies have suggested that with increased levels
of ROS, PCG-1α can bind several transcription factors that
induce the transcription of genes coding for antioxidant
enzymes, which in turn limit ROS production and oxidative
stress (St-Pierre et al., 2003, 2006; Valle et al., 2005; Liang
and Ward, 2006). Other studies have investigated whether
SNP 1444 G > A could affect the protein activity as a
transcriptional coactivator, since the A carriers have low
levels of PCG-1α proteins (Liang and Ward, 2006). In fact,
this could inhibit the transcription of antioxidant genes and
increase oxidative stress. However, there are conflicting results
regarding oxidative stress biomarkers in A carriers and A
non-carriers. Weng et al. (2010) found different levels of
oxidative stress biomarkers between A carriers and A non-
carriers, whereas Lai et al. (2008) did not find any such
differences.
During exercise, muscle contraction causes PCG-1α protein
activation, increases mitochondrial biogenesis, and oxidative
capacity and leads to fast-to slow fiber type conversion
(Rasbach et al., 2010). In these conditions the PCG-1α
protein can bind a transcription factor myocyte enhancer
factor 2 (MEF2). The PGC-1α/MEF2 complex then induces
a remodeling of the fiber composition of skeletal muscle
with greater involvement of oxidative fibers, which confer
resistance to fatigue (Handschin et al., 2003). Zhang et al.
(2007) showed that the amino acid change Gly482Ser
causes an alteration in the binding site for MEF2, thus
affecting the formation of the PGC-1α/MEF2 complex
and inhibiting the switch from fast to slow muscle fibers
with a greater involvement of glycolytic fibers. On the
other hand overexpression of the PGC-1α protein increases
the proportion of oxidative fibers (Lin et al., 2002), while
knock-out models for PGC- 1α show a change from
oxidative to glycolytic fibers (Handschin et al., 2007a). It
has also been observed that increased levels of PGC-1α are
associated with reduced levels of blood lactate (Wende et al.,
2007).
The aim of this study was to evaluate whether or not
the PCG-1α SNP 1444 G > A (Gly482Ser) could affect
oxidative stress markers, both in basal conditions and during an
exercise fatiguing test in ALS patients.
MATERIALS AND METHODS
Subjects
A total of 197 sporadic ALS patients (mean age ± standard
deviation (SD): 62.7 ± 11.7 years old) and 197 healthy
controls (mean age ± SD: 63.4 ± 9.7 years old) were
enrolled in this study. Both groups were recruited
at the Department of Clinical and Experimental
Medicine, Neurological Clinic, University of Pisa (see
Table 1).
Diagnosis of ALS was conducted according to the criteria
of El Escorial, at the onset of the disease. ALS patients showed
the ‘‘upper limbs’’ and/or ‘‘lower limbs’’ clinical form with
mild or moderate functional disability, as assessed by the
clinical scale ALS-FRS-R (The ALS Functional Rating Scale,
1996) and respiratory function was satisfactorily documented
by an FVC >70% predicted. FALS ALS cases based on
a positive family history of the disease were excluded.
Control group included subjects without a medical history of
neurological disorders (Table 2). All recruited subjects were
of Caucasian origin. Both patients and controls gave their
informed consent. The study protocol was approved by the
Ethics Committee of the Great North West Area of Tuscany.
The study was conducted according to Good Clinical Practice
(GCP).
The association study between the polymorphism Gly482Ser
(1444 G > A) in the PGC-1α gene and ALS disease,
was investigated using PCR-RFLP method in 197 patients
(82 F/115 M) and 197 healthy controls (99 F/98 M).
The cellular redox state was assessed on 74 sALS patients
(37 F/37 M) and 65 healthy controls (30 F/35 M), by analyzing
plasma levels of various oxidative stress biomarkers. In
particular we evaluated the advanced oxidation protein
products (AOPPs), as a marker of oxidative damage. We
used the ferric reducing antioxidant power (FRAP) and
total plasmatic thiol groups as markers of non-enzymatic
antioxidants. In addition, in 35 patients (19 F/16 M) we
evaluated the total activity of superoxide dismutase (SOD)
and catalase enzymes, which are antioxidant enzymatic
markers.
Plasmatic levels of oxidative stress markers (AOPP,
FRAP, thiols and lactic acid) during exercise, were
TABLE 1 | Experimental design.
SNP Gly482Ser (1444 G > A) 197 sALS 197 healthy controls
Age (years): mean ± SD 62.7 ± 11.7 63.4 ± 9.7
↓ ↓
Oxidative stress markers: 74 sALS 65 healthy controls
AOPP, FRAP and total thiols 62.4 ± 10.8 74 ± 5.5
Age (years): mean ± SD ↓
Antioxidant activity: total 35 sALS
Sod and Catalase 61.4 ± 11
Age (years): mean ± SD ↓
Oxidative stress markers during 28 sALS
exercise: AOPP, FRAP, thiols and lactate 62.9 ± 9.8
Age (years): mean ± SD
sALS, sporadic ALS patients; SD, standard deviation.
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TABLE 2 | Demographic and clinical features of sALS patients and
controls.
Features sALS patients Controls
Gender: F/M 82/115 99/98
Age (years): mean ± SD 62.7 ± 11.7 63.4 ± 9.7
Age at onset (years): mean ± SD∗ 60.2 ± 11.8 –
Disease duration (months): mean ± SD∗ 83.2 ± 42.5 –
ALS-frs∗ 40.5 ± 7.2 –
Bulbar∗ 29 –
Upper Limbs∗ 46 –
Lower Limbs∗ 61 –
∗Clinical data available for 136 sALS patients. ALS-frs, ALS-functional rating scale.
measured in 28 patients with sALS (15 F/13 M),
undergoing an incremental exercise test on the forearm
muscles.
Exercise Protocols
The exercise test on the forearm muscles was conducted on
sALS patients with a myometer connected to a ‘‘hand-grip’’
(Digital Multi-Myometer, MIE Medical Research Ltd., Leeds,
UK). The exercise protocol consisted in steps in which the
contractile force increased incrementally at 30%, 50%, 70% of
the maximum voluntary contraction (MVC), calculated as the
mean of three sequential contractions at themyometer, expressed
in Newton. Each step includes one minute of intermittent
contractions (about 1/s) and two minutes of rest. The venous
blood samples for determination of oxidative stress markers
were performed at baseline, at the end of each step and 15 min
after the end of the exercise (Scheme 1). This type of exercise
was mainly erobic at the beginning of the test and it became
progressively anerobic, as the force increased, with rapid motor
unit recruitment.
SCHEME 1 | The exercise test on the forearm muscles conducted with a myometer. MVC, maximum voluntary contraction.
Analytical Procedures
Peripheral venous blood samples were collected both for 1444
G > A (Gly482Ser) single nucleotide polymorphism (SNP)
analysis and to monitor the oxidative stress.
SNP 1444 G > A Genotyping in PGC-1α Gene
1444 G > A SNP in PGC-1α gene was determined by
restriction enzyme analysis using genomic DNA extracted from
peripheral blood lymphocytes and the restriction fragment
length polymorphism (RFLP) method.
Genomic DNA was isolated from whole blood samples with
the QIAampr Blood Mini Kit (Qiagen).
PCR reaction was performed in a total volume of 25 µl
consisting of 1.5 pmol each primer: forward 5′-TGCTAC
CTGAGAGAGACTTTG-3′ and reverse 5′-CTTTCATCTTCGC
TGTCATC-3′, 250 µmol/l dNTPs, Buffer (10X), with Mg2+
(25mM), Fast Start Taq [2.5 U] (Roche s.p.a, Italy), and 10 ng
of genomic DNA. Reactions were performed in a Perkin Elmer
thermal cycler for one cycle at 94◦C for 6 min, 30 cycles at 94◦C
for 30 s, 57◦C for 30 s, 72◦C for 30 s, and a final extension at 72◦C
for 7 min.
After digestion with 3 U of MspI (HpaII) restriction
enzymes, the amplified fragments were separated by 3.5%
metaphor-agarose agarose gel electrophoresis, and the restriction
patterns were examinated by ethidium bromide staining and UV
light.
Evaluation of Oxidative Stress Biomarkers
Peripheral venous blood samples were collected to measure the
oxidative stress parameters. Blood samples were immediately
centrifuged at 3000 rpm for 10 min and plasma was stored at
−80◦Cuntil AOPP, FRAP, thiol levels and total SOD and catalase
activity were determined. Briefly, AOPPs, a marker of oxidative
damage to proteins, were determined by mixing plasma with
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phosphate buffered saline (PBS), acetic acid and potassium
iodide. The absorbance was read spectrophotometrically at 340
nm and compared with a solution of chloramine T dissolved
in the same buffer. The data were expressed as nmol/ml of
chloramine equivalents (Witko-Sarsat et al., 1996).
In order to measure non-enzymatic antioxidant properties,
FRAP was assessed according to Benzie and Strain (1996): the
FRAP reagent (sodium-acetate, tripyridyltriazine in hydrochloric
acid, and ferric chloride) was pre-warmed to 37◦C and mixed
with plasma; the absorbance was read after 4 min at 620 nm.
A calibration curve was established by substituting the sample
with a solution of iron sulfate in hydrochloric acid; the data were
expressed in mmol/l.
The content of plasmatic total thiols, which are endogen
antioxidants, was estimated by evaluating the sulphydryl groups
(-SH) present in the molecules, following the protocol described
by Hu (1994).
At the time of determination, 50 µl of plasma were added
to 150 µl of Tris—EDTA, 10 µl of 2, 2-dithiobis nitrobenzoic
acid (DTNB) and 800 µl of absolute methanol. After incubation
at room temperature for 15 min the samples were centrifuged
at 3000 g for 10 min. The absorbance of the supernatant
was assessed at 412 nm and by subtracting the value of
a blank consisting of DTNB. The values were expressed in
µmol/l.
The total enzymatic activity of SOD and catalase was detected
respectively by superoxide dismutase Assay Kit and catalase
assay kit (Cayman, France), respectively, according to the
manufacturer’s instructions.
The SOD assay kit uses a tetrazolium salt to detect
the superoxide radicals generated by xanthine oxidase and
hypoxanthine. Briefly, 10 µl of plasma were mixed with 200 µl
of the diluted radical detector, the reaction was initiated by
adding 20 µl of diluted xanthine oxidase, and the absorbance
was read, after 20 min, at 450 nm. The data were expressed as
U/ml of SOD activity. One unit is defined as the amount of
enzyme needed to exhibit 50% dismutation of the superoxide
radical.
Regarding catalase activity, the kit uses the peroxidatic
function of catalase to determine the enzyme activity.
Twenty microlitres (20 µl) of plasma were mixed with
100 µl of diluited assay buffer, 30 µl of methanol and
20 µl of diluted hydrogen peroxide. After an incubation
for 20 min at room temperature on a shaker, were added
30 µl of catalase purpald and 30 µl of potassium hydroxide.
Followed an incubation for 10 min at room temperature
and further addition of 10 µl of catalase potassium
periodate.
After a final incubation for 5 min, the absorbance of each
sample was read at 540 nm. The data were expressed as
nmol/min/ml.
The assessment of lactic acid levels, carried out by Kit
(Sentinel, Milan-Italy), was conducted in the laboratory of
the Department of Clinical Chemistry of the Santa Chiara
hospital in Pisa. The kit allows an enzymatic-colorimetric
determination of lactate. Lactate is oxidized by lactate oxidase
to pyruvate and hydrogen peroxide, which, in presence of
peroxidase, reacts with N-ethyl-N-(2-hydroxy-3-sulfopropyl)-3-
methylaniline forming a compound, whose color intensity is
proportional to the concentration of lactate in the examined
sample. Plasma (3 µl) were mixed with 300 µl of reagent1,
that consists of reagent1a and reagent1b (provided with this
kit). After an incubation at 37◦C for 10 min, the absorbance of
each sample was read at 540 nm. The data were expressed as
mg/dl.
Data Analysis
To verify whether the allele frequencies were in Hardy-Weinberg
equilibrium, and to assess differences in the genotype and
allele distributions between groups, we used the Chi-square
(χ2) analysis using Microsoft Excel. To evaluate any possible
alteration in the redox balance in sALS patients and the control
group, we used the unpaired two-tailed t testing; and data
were expressed as mean ± SD. The multi-factor ANOVA test,
using the Software StatGraphics, was used to correlate the
oxidative stress data with polymorphism G1444A, considering
each other biomarker studied as covariates. Only for the
ANOVA test, were the values of the considered markers that
did not have a normal distribution, prior to performing the
assay, were normalized by transforming them into logarithmic
data.
The ANOVA test for repeated measures, using the Software
SPSS 20 was used to assess any differences in the redox balance
during the exercise test. The values of lactic acid, for each exercise
step, were normalized compared to the baseline.
A p value< 0.05 was considered significant.
RESULTS
Analysis of 1444 G > A Polymorphism in
PGC-1α Gene
Results obtained from the analysis of the 1444 G > A
polymorphism in the PGC-1α gene are shown in Table 3.
The distributions of genotypes and allelic frequencies were in
agreement with the Hardy-Weinberg equilibrium. We did not
observe any difference in the genotype and allelic distribution
between the sALS patients and healthy controls.
Evaluation of Oxidative Stress Biomarkers
sALS patients had significantly higher AOPP plasma levels
(397.91 ± 206.97 nmol/ml; p < 0.001) than the healthy controls
(Figure 1A). Likewise, patients with sALS had a significantly
lower plasma levels of FRAP (Figure 1B) and thiols (Figure 1C)
than the controls.
Correlation Between Oxidative Stress
Biomarkers and 1444 G > A SNP in
PGC-1α Gene
The study population (ALS patients and controls) was divided
into three groups according to genotypes in GG, GA and
AA. We did not observe any difference in the levels of
the oxidative stress biomarkers AOPP (Figure 2A), lactate
(Figure 2B), FRAP (Figure 2C), thiols (Figure 2D), SOD
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TABLE 3 | Distribution of the genotypes and allele frequencies of the SNP
G1444A in ALS patients and in controls.
Genotype sALS Healthy OR IC p
n (%) controls 95% value
n (%)
GG (Gly482Gly) 64 (32) 77 (39) 1.00∗
GA (Gly482Ser) 98 (50) 85 (43) 0.15
AA (Ser482Ser) 35 (18) 35 (18) 0.53
A carriers (482Ser) 133 (68) 120 (61) 1.33 0.88; 2.02 0.17
Allel A (482Ser) frequency 0.43 0.39 0.35
Total 197 197
∗Reference value for OR (odds ratio); IC, confidence interval; p value obtained by
χ2 analysis.
(Figure 2E) and catalase activity (Figure 2F) between the three
groups. The same results were obtained by comparing each
of these ALS subgroups with the control group (data not
shown).
Effects of Exercise on Oxidative Stress
Biomarkers
Plasma levels of AOPP, FRAP and thiols remained stable
during exercise until 15 min after physical activity (data not
shown). Variations were observed in lactic acid levels during
and after exercise [F(2.182, 34.911) = 15.5, p < 0.001]. In particular,
in sALS patients we found increased lactate levels at 30%
(p < 0.01), 50% (p < 0.01) and 70% (p < 0.001) of maximal
voluntary contraction (MVC) compared to baseline levels and
at 70% (p < 0.05) vs. 30% of MVC. At the recovery we
observed a decrease in lactate at 50% (p < 0.05) and 70%
(p < 0.001) of MVC although we did not observe any difference
comparing the curves of ALS patients and healthy subjects
(Figure 3).
Relationship Between the Variations in
Oxidative Stress Biomarkers Levels During
Exercise and G1444A SNP in PGC-1α Gene
No changes were observed in the levels of FRAP and thiols in the
three groups of patients divided according to genotypes in GG,
GA and AA (data not shown). However, changes were observed
in AOPP and lactic acid levels. In fact, subjects harboring the
482Ser allele (AA) showed increased AOPP levels during and
after exercise than the other two groups (GG and GA genotype)
which had stackable levels. This variation was significant at
50% of MVC (p < 0.05, GG vs. AA; p = 0.05, GA vs. AA)
and at recovery (p = 0.01, GG vs. AA; p < 0.01, GA vs. AA;
Figure 4A).
FIGURE 1 | Evaluation of plasma advanced oxidation protein products (AOPP; A), ferric reducing antioxidant power (FRAP; B) and thiols (C) levels in
sALS patients vs. controls. p value obtained by t-Student test; ∗∗∗p < 0.001.
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FIGURE 2 | Association between SNP G1444A and peripheral oxidative damage markers. (A) AOPP, (B) lactate, (C) FRAP (D), thiols (E), SOD and
(F) catalase. p value obtained by multi-factor ANOVA test.
Finally, higher levels of lactic acid were observed during
exercise in patients harboring AA genotype, compared to the
other two groups. In particular, subjects with AA genotype show
significantly increased levels of lactic acid at 30% (p < 0.01) and
50% (p < 0.001) of the MVC, compared to subjects with the GG
genotype (Figure 4B).
DISCUSSION AND CONCLUSIONS
In vitro studies support the hypothesis that PGC-1α plays
a crucial role in protecting the mitochondria from oxidative
stress through the reduced accumulation of ROS and reduced
apoptotic cell death (Valle et al., 2005; St-Pierre et al., 2006).
These data prompted us to evaluate the role of 1444 G > A
polymorphism in response to oxidative stress, in basal conditions
and during physical activity in sALS patients. ALS is in fact a
motor neuronal disorder of a degenerative origin where oxidative
stress seems to be one of the pathogenic players and muscle
exercise appears to be an important phenotype modulator.
We believe that this is the first study investigating PGC-1α
SNPs in ALS patients. No differences were found between
patients and controls as far as the distribution of 482Ser allele
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FIGURE 3 | Lactate curve during incremental workload forearm
exercise; normalized values from baseline. p value obtained by ANOVA
test for repeated measures [F(2.182, 34.911) = 15.5, p < 0.001]. ∗∗p < 0.01;
∗∗∗p < 0.001.
is concerned, suggesting that the PGC-1α Gly482Ser variant is
not associated with the disease. This in line with previous data
on mice models showing no direct effect of PGC-1α protein
expression on ALS onset (Liang et al., 2011; Da Cruz et al.,
2012).
To assess the oxidative stress conditions in sALS patients,
we have measured plasma levels of the AOPPs, as a marker
of oxidative damage to proteins, and the FRAP and total
thiol groups, as non-enzymatic antioxidants markers. We
also investigated whether Gly482Ser polymorphism affects the
levels of the analyzed oxidative stress biomarkers. Patients
had significantly higher AOPP levels than the controls, thus
confirming the presence of oxidative damage in ALS. These
results are in agreement with previous studies indicating that
oxidative stress is implicated in this disease (Bogdanov et al.,
2000; Simpson et al., 2004; Siciliano et al., 2007; Kabuta
et al., 2015). Bogdanov et al. (2000) detected increased levels
of 8-OHdG in biological fluids of ALS patients compared to
controls. Studies conducted by Simpson et al. (2004) and later
confirmed by Kabuta et al. (2015) highlight increased levels of
4-Hydroxynonenal, which is a product of lipid peroxidation, in
the spinal cord, motor cortex, cerebrospinal fluid, plasma/serum
and urine of sALS patients compared to patients with other
neurodegenerative diseases, controls with diseases of non
degenerative origin or healthy controls.
Our results also show a reduction in antioxidant defenses,
FRAP and thiols, in sALS patients, again confirming previous
studies showing decreased antioxidant reserves in ALS. Keizman
et al. (2009) showed low serum levels of uric acid, which
represents about 60% of the FRAP value, in ALS patients
compared to healthy subjects. Other studies have shown
decreased total thiols (Baillet et al., 2010) and GSH levels in sALS
patients compared to controls (Weiduschat et al., 2014). Overall,
our findings of increased AOPPs levels and decreased FRAP and
thiol levels in sALS patients seem to reflect an altered redox
balance, thus confirming the key role of oxidative stress in ALS
pathogenesis.
Under rest conditions, on the other hand, plasma levels
of oxidative stress markers (AOPP, lactate, FRAP, total thiol
groups, SOD and catalase activity) betweenALS patients with GG
genotype and A carriers, showed no differences. Thus, the allelic
variant A does not seem to exert a negative role in conditions
of oxidative stress. It could be speculated that in the PGC-1α
protein, the 482 amino acid location, whether or not Gly or Ser,
is not a critical domain for interaction with antioxidant gene
promoters. However, under rest conditions, the PGC-1α protein
is in the cytoplasm in an inactive conformation state and it is
activated only in response to stimuli such as fasting, cold, physical
activity and high elevation of ROS levels (Park et al., 2014; we did
not measure ROS levels in this study).
Physical activity plays a key role in breaking or rebalancing
the cellular redox balance (Childs et al., 2001; Iorio, 2003;
Waring et al., 2003), and augmenting ROS levels can increase the
FIGURE 4 | Relationship between blood curve of AOPP (A) and lactate (B) during incremental workload forearm exercise and SNP G1444A in PCG-1α
gene. ∗GG vs. AA; $GG vs. GA; ∗, $p < 0.05, ∗∗, $$p < 0.01, ∗∗∗p < 0.001.
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oxidative damage (Bloomer et al., 2005). Based on this evidence,
we investigated possible alterations in the redox balance in
response to exercise in a subgroup of sALS patients performing
erobic exercise. While lactic acid increased, as expected for this
type of exercise, changes in plasma levels of AOPP, FRAP and
thiols were not detected during or after muscle exercise in sALS
patients. These markers remained roughly constant for up to
15 min after the end of the test. The absence of oxidative
stress responses to exercise could nonetheless still be in line
with what is known, in healthy subjects, regarding the time
relapsing curve of the variations in oxidative stress biomarkers
levels after anerobic or erobic exercise. This occurs several hours
after the end of the exercise, such as 6, 9, 24 h after exercise,
which is a latency considered as compatible with the induction
of enzyme machinery behind the oxidative stress markers we
considered (Lewin, 2010). For ethical reasons, to avoid excessive
discomfort to the patient, we have decided to limit the duration of
experimental session and to do not collect samples several hours
after the end of the exercise.
PGC-1α regulates the expression of various genes coding
for several enzymes involved in fatty acid oxidation. Oxidative
phosphorylation and intensive training lead to an increase in
PGC-1α levels, which in turn can increase the oxidative capacity
in skeletal muscle. A few studies have been conducted to test
the possible effect of PGC-1α on athletic performance (Eynon
et al., 2010). Lucia et al. (2005) reported an association between
exercise and Gly482Ser polymorphism (1444 G > A), the minor
A allele being significantly less frequent in athletes than in
controls. The 482Ser allele is associated with poor physical
capacity, while the Gly482 allele appears to be a genetic factor that
increases beneficial muscular endurance (Nishida et al., 2015).
In this work we subdivided sALS patients according to
genotype, GG genotype, GA genotype and AA genotype, in
order to assess whether the 482Ser allele affects oxidative stress
biomarker levels before, during and after exercise. While FRAP
and thiol levels did not differ between the three groups, patients
harboring the AA genotype showed, during exercise, higher
levels of AOPP compared to the other two groups, specifically
at 50% of maximal voluntary contraction (MVC) and at recovery
after exercise. In addition, subjects with the AA genotype showed
significant greater exercise-related lactic acid levels at 30%
(GG vs. AA) and at 50% (GG vs. AA) of MVC, compared
to subjects harboring GG genotype. The patients with the GA
genotype showed intermediate levels of lactic acid, however these
data were not statistically significant.
In patients with the AA genotype, the increase in lactate
production during the incremental exercise test, may induce an
increase in free radicals which, in turn, could damage proteins; in
fact we observed an increase in AOPP levels in A carrier subjects.
Therefore, although there were no variations in basal oxidative
stress biomarkers levels in the 482Ser carriers compared to the
Gly482 patients, our results showed that the occurrence of 482Ser
allele may contribute to increased oxidative damage during
physical activity.
Mechanisms such as the impairment of the MEF2 binding
site in PGC-1α, as a result of changes in Gly482Ser amino
acid, impede the fast-to-slow fiber type conversion during the
endurance response in Gly482Ser carriers (Steinbacher et al.,
2015). This can be taken into account to provide a pathogenic
substrate to our results. This would then determine a greater
involvement of anerobic glycolytic fibers to exercise, with the
consequent accumulation of lactic acid, this in turn being one of
the responsible factors of increased hydroxyl radical and further
oxidative damage. Studies on mRNA expression profiles in
targeted tissues would be useful in confirming this. Considering
the PGC-1α protective role against muscle atrophy (Da Cruz
et al., 2012), we can assume that synthetic molecules able to
induce PGC-1α expression, delivered systemically or applied
specifically to themuscle, could be used as adjuvant treatments in
ALS patients to improve mitochondrial function, reduce atrophy
and improve daily physical activity, thus contributing to a better
quality of life in this disease.
In conclusion, the results obtained in this work suggest that
the Gly482Ser SNP in the PGC-1α gene is related to the lower
resistance to exercise-related oxidative stress in ALS. Knowing
the genotype of each patient might be helpful in order to
design appropriate training protocols aimed at maintaining the
functionality of the skeletal muscle for as long as possible.
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